Women's Health and Sexually Transmitted Infections

Sinochips Diagnostics Women’s Health and STI portfolio provides accurate, reliable results–enabling clinicians and labs to elevate patient care in reproductive health.

BD MAX™ Vaginal Panel

Real-Time Polymerase Chain Reaction (RT-PCR)

The BD MAX™ Vaginal Panel performed on the BD MAX System is an automated qualitative in vitro diagnostic test for the direct detection of DNA targets from bacteria associated with bacterial vaginosis (qualitative results reported based on detection and quantitation of targeted organism markers), Candida species associated with vulvovaginal candidiasis, and Trichomonas vaginalis from vaginal swabs in patients who are symptomatic for vaginitis/vaginosis. The test utilizes real-time polymerase chain reaction (PCR) for the amplification of specific DNA targets and utilizes fluorogenic target-specific hybridization probes to detect and differentiate DNA from:

  • Bacterial vaginosis markers(Individual markers not reported)
      • Lactobacillus spp. (L. crispatus and L. jensenii)
      • Gardnerella vaginalis
      • Atopobium vaginae
      • Bacterial Vaginosis Associated Bacteria-2 (BVAB-2)
      • Megasphaera-1
  • Candida (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis)
  • Candida glabrata
  • Candida krusei
  • Trichomonas vaginalis

BD MAX™ CT/GC/TV Panel

Real-Time Polymerase Chain Reaction (RT-PCR)

The BD MAX™ CT/GC/TV assay, as performed using the BD MAX System, incorporates automated DNA extraction and real-time polymerase chain reaction (PCR) for the direct, qualitative detection of DNA from Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC) and/or Trichomonas vaginalis (TV). The assay may be used for detection of CT and/or GC DNA in male urine specimens, and the detection of CT, GC and/or TV DNA in female urine specimens, clinician-collected female endocervical swab specimens and patient-collected vaginal swab specimens (in a clinical setting). The assay is indicated for use to aid in the diagnosis of chlamydial urogenital disease, gonococcal urogenital disease and/or trichomoniasis in asymptomatic and symptomatic individuals.

covid-19 test 72 hour turnaround time

Service Highlights

  • FDA-cleared IVD assays
  • Results available 3 days after sample receipt at Sinochips Diagnostics Laboratory
  • Results directly to ordering HCP using automated LIMS

HSV-1, HSV-2, VZV, CMV Panel

Real-Time Polymerase Chain Reaction (RT-PCR)

The HSV-1, HSV-2, VZV, CMV assay performed on the BD MAX™ System is an automated qualitative in vitro diagnostic test for the direct detection of DNA targets from herpes simplex virus 1 (HSV-1), herpes simplex virus 2 (HSV-2), varicella-zoster virus (VZV), and cytomegalovirus (CMV). The test utilizes real-time polymerase chain reaction (PCR) for the amplification of specific DNA targets and utilizes fluorogenic target-specific hybridization probes to detect and differentiate DNA from:

  • • Herpes simplex virus 1 (US4/gG gene)
  • • Herpes simplex virus 2 (US6/gD gene)
  • • Varicella-zoster virus (ORF71 gene)
  • • Cytomegalovirus (DNA polymerase gene)
  • • Sample Processing Control (SPC) (Drosophila DNA)

This assay is intended to aid in the diagnosis of individuals with a clinical presentation consistent with HSV-1, HSV-2, VZV, and/or CMV.

 
covid-19 test 72 hour turnaround time

Service Highlights

  • Laboratory developed IVD tests
  • Results available 3 days after sample receipt at Sinochips Diagnostics Laboratory
  • Results directly to ordering HCP using automated LIMS

Sinochips STI Panel

Real-Time Polymerase Chain Reaction (RT-PCR)

  • The Sexually Transmitted Infections (STI) Panel is a comprehensive laboratory-developed test designed for the semi-quantitative detection of a wide array of pathogens commonly responsible for sexually transmitted infections. This panel is intended for use as a diagnostic aid in the identification and management of sexual health concerns. It assists in the detection of the following pathogens:
  
  •   Chlamydia trachomatis
  • •  Neisseria gonorrhoeae
  • •  Mycoplasma genitalium
  • •  Treponema pallidum
  • •  Trichomonas vaginalis
  • •  Ureaplasma urealyticum
  • •  Haemophilus ducreyi
  • •  Human Herpes simplex virus-1 (HSV-1)
  • •  Human Herpes simplex virus-2 (HSV-2)
  • •  Human papillomavirus 16 (HPV 16)
  • •  Human papillomavirus 18 (HPV 18)
  • •  Human papillomavirus 45 (HPV 45)
  •  
  • This assay is intended to aid in the diagnosis of individuals with a clinical presentation consistent with sexually transmitted infections.

Sinochips Vaginitis Panel

Real-Time Polymerase Chain Reaction (RT-PCR)

The Vaginitis (VAG) Panel is a comprehensive, laboratory-developed test designed for the semi-quantitative detection of a wide array of pathogens commonly associated with vaginal infections. This panel aids in the identification and differentiation of bacterial, fungal, and parasitic pathogens, providing valuable insights for accurate diagnosis and targeted treatment.

The VAG Panel detects the following targets:

Bacteria

  • o Atopobium vaginae
  • o Bacteroides fragilis
  • o Escherichia coli
  • o Enterococcus spp.
  • o Gardnerella vaginalis
  • o Lactobacillus spp. (L. jensenii, L. crispatus, L. gasseri, L. iners)
  • o Megasphaera (Type 1 and Type 2)
  • o Mobiluncus spp. (M. curtisii, M. mulieris)
  • o Mycoplasma hominis
  • o Prevotella bivia
  • o Streptococcus agalactiae (Group B Streptococcus)
  • o Staphylococcus aureus (with mecA gene)
  • Ureaplasma urealyticum
  •  
  • Fungi
  • • Candida spp.:
  • o Candida albicans
  • o Candida glabrata
  • o Candida tropicalis
  • o Candida krusei
  • o Candida lusitaniae
  • o Candida parapsilosis
  • o Candida dubliniensis
  •  
  • Parasites
  • Trichomonas vaginalis
 

Sinochips Human Papillomavirus (HPV) Genotyping Test

Real-Time Polymerase Chain Reaction (RT-PCR)

  • The Human Papillomavirus (HPV) Genotyping Test is a comprehensive molecular diagnostic assay designed for the qualitative detection and genotyping of high-risk and low-risk HPV types associated with cervical cancer, genital warts, and other HPV-related diseases. This test provides critical information for screening, risk stratification, and clinical management of HPV infections, enabling healthcare providers to make informed decisions for patient care.

  • The HPV Genotyping Test detects the following HPV types:

• HPV 16

• HPV 18

• HPV 45

• HPV 31

• HPV 33

• HPV 51

• HPV 39

• HPV 35

• HPV 52

• HPV 68

• HPV 59

• HPV 56

• HPV 66

• HPV 58

Partnering with Sinochips Diagnostics Is Easy

Partnering with Sinochips Diagnostics Is Easy

1. Contact us

Contact Sinochips Diagnostics (877) 746-6244. Within 1 business day an account will be created, and you will receive access to our result portal.

2. Receive sample collection kits

Within 1-2 days the healthcare provider (HCP) will receive the sample collection kit for the test.

3. Send samples to us

After the test is ordered by the HCP and patient sample is collected, the HCP will put the sample, and the test order/requisition form in the provided bag and deliver to Sinochips Diagnostics.

4. Receive results

The HCP will receive the results through our result portal within 72 hours.